December 1, 2014 / 3:03 PM / in 3 years

BUZZ-Aeterna Zentaris Inc: Licenses drug to China-based company

** Canadian company’s U.S.-listed shares up 13.5 pct at 60 cents in early trading

** Toronto-listed shares up 9.8 pct at 67 Canadian cents

** Company licenses lead anti-cancer compound zoptarelin doxorubicin to China-based Sinopharm A-Think Pharmaceuticals Co Ltd for $1 mln

** Aeterna Zentaris licenses rights to develop the drug in China, Hong Kong and Macao

** Up to Friday’s close, Aeterna’s U.S. shares had slumped about 62 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below